These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3080872)

  • 1. Acquired von Willebrand syndrome due to an inhibitor specific for von Willebrand factor antigens.
    Lazarchick J; Pappas AA; Kizer J; Hall SA
    Am J Hematol; 1986 Mar; 21(3):305-14. PubMed ID: 3080872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
    Joist JH; Cowan JF; Zimmerman TS
    N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired von Willebrand's syndrome due to an inhibitor of IgG specific for von Willebrand's factor in polycythemia rubra vera.
    Mohri H; Ohkubo T
    Acta Haematol; 1987; 78(4):258-64. PubMed ID: 3122493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired von Willebrand disease in patients with polycythemia rubra vera.
    Mohri H
    Am J Hematol; 1987 Oct; 26(2):135-46. PubMed ID: 3116841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor.
    Mohri H; Noguchi T; Kodama F; Itoh A; Ohkubo T
    Am J Clin Pathol; 1987 May; 87(5):663-8. PubMed ID: 3107370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage?
    Greaves M; Pickering C; Knight G; Boulton AJ; Ball J; Ward JD; Preston FE
    Diabetologia; 1987 Mar; 30(3):160-5. PubMed ID: 3108060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases.
    Sampson BM; Greaves M; Malia RG; Preston FE
    Br J Haematol; 1983 Jun; 54(2):233-44. PubMed ID: 6405778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycythemia vera-associated acquired von Willebrand syndrome despite near-normal platelet count.
    Tefferi A; Smock KJ; Divgi AB
    Am J Hematol; 2010 Jul; 85(7):545. PubMed ID: 20575028
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective absence of large forms of factor VIII/von Willebrand factor in acquired von Willebrand's syndrome. Response to transfusion.
    Meyer D; Frommel D; Larrieu MJ; Zimmerman TS
    Blood; 1979 Sep; 54(3):600-6. PubMed ID: 313821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement therapy in platelet-type von Willebrand disease.
    Takahashi H
    Am J Hematol; 1985 Apr; 18(4):351-62. PubMed ID: 3919572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procoagulant specificity of factor VIII inhibitor.
    Yang HC; Kuzur M
    Br J Haematol; 1977 Nov; 37(3):429-33. PubMed ID: 304738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilms' tumour with acquired von Willebrand's disease.
    Han P; Lou J; Wong HB
    Aust Paediatr J; 1987 Aug; 23(4):253-5. PubMed ID: 2827618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
    Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
    Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of antibody-induced acquired von Willebrand Syndrome.
    Gan TE; Sawers RJ; Koutts J
    Am J Hematol; 1980; 9(4):363-71. PubMed ID: 6782864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional variant of type I von Willebrand disease.
    Tavori S; Tatarsky I
    Am J Hematol; 1987 Feb; 24(2):189-97. PubMed ID: 3101492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.